Yumeng Mao
Universitetslektor vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Yumeng Mao
- E-post:
- yumeng.mao@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
- ORCID:
- 0000-0001-6142-6628
Nyckelord
- drug discovery
- cancer immune checkpoint
- immune resistance
- crispr-cas9
- pd1
- pdl1
- myeloid cells
Publikationer
Senaste publikationer
Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
Ingår i Journal of Clinical Investigation, 2024
- DOI för Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
- Ladda ner fulltext (pdf) av Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
Ingår i Nature Communications, 2024
- DOI för Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
- Ladda ner fulltext (pdf) av Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
Ingår i Journal of Clinical Investigation, 2023
- DOI för Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
- Ladda ner fulltext (pdf) av Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
Ingår i Frontiers in Immunology, 2021
- DOI för Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
- Ladda ner fulltext (pdf) av Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25(+)/CD54(+) NK cells
Ingår i EMBO Reports, 2021
- DOI för Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25(+)/CD54(+) NK cells
- Ladda ner fulltext (pdf) av Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25(+)/CD54(+) NK cells
Alla publikationer
Artiklar i tidskrift
Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
Ingår i Journal of Clinical Investigation, 2024
- DOI för Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
- Ladda ner fulltext (pdf) av Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
Ingår i Nature Communications, 2024
- DOI för Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
- Ladda ner fulltext (pdf) av Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
Ingår i Journal of Clinical Investigation, 2023
- DOI för Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
- Ladda ner fulltext (pdf) av Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
Ingår i Frontiers in Immunology, 2021
- DOI för Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
- Ladda ner fulltext (pdf) av Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25(+)/CD54(+) NK cells
Ingår i EMBO Reports, 2021
- DOI för Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25(+)/CD54(+) NK cells
- Ladda ner fulltext (pdf) av Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25(+)/CD54(+) NK cells
Ingår i Oncoimmunology, 2021
- DOI för Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients
- Ladda ner fulltext (pdf) av Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients
Ingår i Current Medicinal Chemistry, s. 5654-5674, 2020
Discovery of PROTAC molecules that selectively degrade the IRAK3 pseudokinase
Ingår i Journal of Medicinal Chemistry, s. 10460-10473, 2020
Ingår i Cancer Immunology and Immunotherapy, s. 1391-1401, 2020
- DOI för Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
- Ladda ner fulltext (pdf) av Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
What industry can teach academia
Ingår i Science, s. 1342-1342, 2019